Name: ICTR-PHE 2014
Start: 2014-02-10T12:00:00+01:00
End: 2014-02-14T16:30:00+01:00
Location: Centre International de Conferences de Geneve (CICG)

ICTR-PHE 2014

from Monday 10 February 2014 (12:00) to Friday 14 February 2014 (16:30)
Centre International de Conferences de Geneve (CICG)

: Sessions

: Talks

: Breaks

10 Feb 2014

11 Feb 2014

12 Feb 2014

13 Feb 2014

14 Feb 2014

08:30	Nuclear Medicine - Thomas Beyer Ulli Koster (until 10:00)
08:30	Clinical experience with radionuclide therapies - Irene Virgolini
09:00	From bench to bedside: development and early clinical results of 188Re-SSS/Lipiodol for HCC treatment - Nicolas Lepareur
09:15	PIP: a compact recirculating accelerator for the production of medical isotopes - Adina Toader
09:30	Gamma Probe Based on Scintillation Crystal and Silicon Photomultiplier - Konstantin Zhukov
09:45	Preclinical studies and radiopharmaceutical developments with 64Cu produced by ARRONAX facility - Mickael Bourgeois
10:00	--- Coffee Break ---
10:30	Detectors & Imaging - Alberto Del Guerra Denis Dauvergne (until 12:30)
10:30	From CERN to PET/MR - David Townsend Slides
11:00	Software challenges and opportunities for multidisciplinary PET/CT and PET/MR imaging - Dimitris Visvikis Slides
11:30	Prompt gamma imaging of proton pencil beams at clinical beam current - Julien Smeets
11:45	Prediction of β+-activity distributions from PT-PET by means of a yield approach - Stephan Helmbrecht
12:00	ProXY – High performance monolithic pixel tracker for proton tomography - Piero Giubilato
12:15	The recent developments of the FLUKA Monte Carlo code oriented to its applications in Hadrontherapy - Paola Sala

08:30	ESTRO lecture - Jean Bourhis (until 09:00)
08:30	Individualized Radiation Oncology – harnessing clinics, biology and high technology - Michael Baumann
09:00	Plenary session - Manjit Dosanjh Jacques Bernier (until 10:00)
09:00	Health implications and applications in space - Christer Fuglesang
09:30	The convergence of science - the way to develop novel radiation oncology technologies for the future - Dag Rune Olsen
10:00	--- Coffee Break ---
10:30	Plenary session - Manjit Dosanjh Jacques Bernier (until 12:00)
10:30	Current status of Carbon Ion Radiotherapy at NIRS - Hirohiko Tsujii
11:00	Radioisotopes - the "fuel" for nuclear medicine - Ulli Koster
11:30	Medical applications at CERN - Steve Myers

08:15	GH Fletcher Lecture - Ritsuko Komaki (until 08:50)
08:15	Host and Tumor Immunity: Local and Systemic Opportunities to Enhance Tumor Curability by Radiotherapy - Ralph Weichselbaum
08:50	From new therapeutic targets to personalized treatment - Søren Bentzen (until 10:05)
08:50	Identification of new therapeutic targets - Conchita Vens
09:15	Single-dose radiotherapy: from learning curve to long-term clinical outcome - Carlo Greco
09:40	From bench to bedside: experience of the glioblastoma model for the optimization of radiosensitization - Elizabeth Moyal
08:50	Radiotherapy - Hypoxic modification of radiotherapy - Marianne Nordsmark (until 10:05)
08:50	Hypoxia-induced gene expression - Marianne Koritzinsky
09:15	Impact of tumor autophagy on solid tumors response to IR: role of the tumor stroma - Eric Deutsch
09:40	Hypoxia: where to go from here? - Jens Overgaard
10:05	--- Coffee Break ---
10:30	EORTC symposium - Philippe Maingon Sofia Rivera (until 11:50)
10:30	The new business model of the EORTC - Emad Shash
10:50	The Radiation Oncology Group of the EORTC: from the past to the future - Philippe Maingon
11:10	The new drug and radiotherapy working party - Conchita Vens
11:30	An example of the integrated model: the EORTC DAHANCA-1219 trial - Vincent Gregoire
10:30	Proffered papers - Biology II - Raj Jena Wolfgang Dörr (until 11:50)
10:30	Enhanced RBE of sub-micrometer focused low-LET protons - Thomas Schmid
10:40	Expression of common or species specific DNA damage-repair pathway related genes in thymus of low-dose-rate irradiated AKR/J and ICR mice - Hee Sun Kim
10:50	[18F] HX4 PET imaging of tumour hypoxia in HNSCC patients - Karen Zegers
11:00	Inhibition of tumour growth using the small molecule Cathepsin L inhibitor, KGP94 - Thomas Wittenborn
11:10	Delayed and Persistent Response of Human Mitochondria after Single Exposure to 0.5 to 4 Gy of Gamma Radiation - Winnie Kam
11:20	Dosimetric considerations to determine the optimal technique for localized prostate cancer - Peter Kuess Slides
11:30	Auger electron emitters labeled to monoclonal antibodies trigger cell membrane-mediated bystander effects - Jean-Pierre Pouget
11:40	Comparing Ion Computed Tomography under clinical constraints - David Hansen
10:30	Proffered papers - Physics III - Ken Peach Denis Dauvergne (until 11:50)
10:30	Ultimate Time Resolution in Time-of-Flight PET - Paul Lecoq
10:40	Ultrafast PET Detectors Based on Digital SiPMs and Their Use in In-Situ PET and Prompt Gamma Ray Imaging - Dennis Schaart Slides
10:50	4D Dose calculations and 4D PET image reconstruction using deformable tetrahedral models of moving organs - Petre Manescu
11:00	Motion compensated reconstructions in PET-based ion beam treatment verification for moving target - Chiara Gianoli
11:10	Usage of long axial crystals for PET applications: the AX-PET demonstrator and beyond - Chiara Casella Slides
11:20	Realistic on-the-fly dose calculation for low energy X-rays Intra-Operative Radiation Therapy - Marie Vidal
11:30	A single device for mechanical and radiation Quality Assurance measurements of medical accelerators - John Wong Ernesto Valverde
11:40	A combined electrical impedance tomography and cone beam CT for radiation therapy monitoring - Manuchehr Soleimani
11:50	Proffered papers - Biology III - Wolfgang Dörr Raj Jena (until 12:30)
11:50	Oxygen ions achieve better tumour control probability in hypoxic tumours than carbon ions do - Niels Bassler
12:00	Direct evaluation of ion beam radiobiological parameters from clinical data: an alternative approach to the RBE - Andrea Attili
12:10	Equivalent uniform dose (EUD) based biological optimization for carbon ion therapy - Sarah Brüningk Slides
12:20	Variance Based Sensitivity Analysis of Biological Uncertainties in Carbon Ion Therapy - Florian Kamp Slides
11:50	Proffered papers - Physics IV (Hadrons) - Sandro Rossi (until 12:30)
11:50	TOF-PET scanner configurations for quality assurance in proton therapy: a patient case study - Peter Dendooven Slides
12:00	Implementation of a GPU Monte Carlo protons transport code for dose calculations: methods and challenges - Daniel Maneval Slides
12:10	Fast pencil beam dose calculation for hadron therapy on GPU - Joakim Da Silva
12:20	Parameterization of lateral dose profiles for proton therapy application at CNAO - Martina Mori
11:50	Profferred papers - Radiotherapy I - Marcel Verheij (until 12:30)
11:50	Modelling acute urinary toxicity after radiotherapy for prostate cancer - Tiziana Rancati Viviana Caillo
12:00	Mediators associated to the inflammatory response in prostate cancer patients undergoing RT: preliminary results - Bedini Nice
12:10	Daily variation in rectal size and position during prostate radiotherapy measured from helical tomotherapy CT scans - Jessica Scaife
12:20	Clinical experience with adaptive radiotherapy for muscle invasive bladder cancer - Anne Vestergaard Slides

08:30	Panel discussion - Clinical trials in particle therapy - Vikram Bhadrasain Manjit Dosanjh (until 09:45) slides
08:30	Panel discussion - Jürgen Debus Roberto Orecchia James Cox Hirohiko Tsujii
08:30	Radiosensitivity modulation - new angles of attack - Richard Kolesnick (until 09:45)
08:30	Growth factor and integrin receptor targeting - there is more to it than just inhibition - Nils Cordes
08:55	Notch and radiotherapy: does it matter? - Marc Vooijs
09:20	Head-and-neck cancers: towards new, intriguing fractionation schedules - Jean Bourhis
09:45	--- Coffee Break ---
10:15	Proffered papers - Biology V - Vikram Bhadrasain Tim Maughan (until 11:45)
10:15	Radiosensitization of Non–Small Cell Lung Cancers by Targeting Ionizing Radiation-Induced Activation of ADAM17 - Martin Pruschy
10:30	Do physiological relevant doses of biguanides have any role in cancer treatment? - Morten Busk
10:45	Oral mucosal radiation response (mouse) - relevance of ceramide-induced apoptosis? - Wolfgang Dörr
11:00	A phase I/II study of proton and hyperthermia in primary unresectable and recurrent adult soft tissue sarcoma - Niloy Datta Slides
10:15	Proffered papers - Biology VI - Norman Coleman Kevin Prise (until 11:35)
10:15	Radiobiological Considerations for Retreatment of Central Nervous System Tumours - Bleddyn Jones
10:25	Gadolinium based nanoparticles for radiosensitization of head and neck squamous cell carcinoma - Lucie Sancey
10:35	Noninvasive Imaging of Radiation-Induced Lung Inflammation with Positron Emission Tomography (PET) in a Murine Model - Ken Kang Hsin Wang Jin Zhang
10:45	The use of ‘planned overshoot’ for reducing dose to healthy tissue and improve treatments robustness for scanned proton beams - Francesca Albertini Slides
10:55	Clinical testing of an in-room imaging system for patient setup verification in particle therapy - Guido Baroni
11:05	Reduced side effects by proton microchannel radiotherapy – study in a human skin model - Stefanie Girst Slides
11:15	Entervision Wp4. Biological Dosimetric Phantom. Proof Of Concept Preliminary Results - Thiago Viana Miranda Lima
11:25	A knowledge exchange case study: computational radiotherapy at Cambridge - Michael Simmons
10:15	Proffered papers - Physics VI (Hadrons) - Ugo Amaldi Hirohiko Tsujii (until 11:45)
10:15	Intra-fraction tumor tracking based on a surrogate-driven 4D CT motion model in particle radiation therapy - Guido Baroni
10:25	Prompt Gamma Imaging at MGH with LaBr3 Scintillating Crystals - Joao Seco
10:35	Nanoparticles and protontherapy: disentangling possible physical effects - Yolanda Prezado
10:45	95 MeV/A carbon fragmentation studies for hadrontherapy: measurements and comparisons with GEANT4 simulations - Marc Labalme
10:55	Properties of therapeutic He, Li and O beams studied with Geant4 - Lucas Burigo
11:05	Automatic beam dose profiler for scanned pencil beams (protons and carbon ions) at the CNAO hadrontherapy facility - Aurora Tamborini
11:15	Proton Interaction Vertex Imaging for carbon therapy quality control - Regina Rescigno
11:25	Dual energy CT to reduce range uncertainties in hadrontherapy - Guillaume Landry
11:35	Research and development of a TOF-based multi-slit collimated camera for online hadrontherapy monitoring - Marco Pinto
11:45	--- Lunch ---

12:00	--- Lunch ---
13:00	Welcome addresses - Rolf Heuer Manjit Dosanjh Representative of the Geneva state Jacques Bernier
13:30	The Higgs boson and our life - Jacques Bernier Rolf-Dieter Heuer (until 14:00)
13:30	The Higgs boson and our life - Fabiola Gianotti Slides
14:00	Radiobiology - Kevin Prise Marco Durante (until 16:00)
14:00	Ion Beam Radiobiology: From the Lab to the Clinic - Eleanor Blakely Slides
14:30	International Cancer Expert Corps (ICEC) - Norman Coleman
15:00	New challenges for biologically adapted ion beam treatment planning: single and multi-ion approaches - Emanuele Scifoni Slides
15:15	RBE and DNA damage variation along monoenergetic and modulated Bragg peaks of a 62 MeV therapeutic protons beam - Kevin Prise Slides
15:30	Influences of aberrant mitochondrial DNA in cancer and cancer therapy - Marike van Gisbergen
15:45	Hpv Status and Effect on Radiosensitivity in Head and Neck Cancer Tumor Xenografts - Brita S Sørensen
16:00	--- Coffee ---
16:30	Radiobiology - Marco Durante Kevin Prise (until 17:00)
16:30	Rectal cancer and fractionation sensitivity in the neo-adjuvant radiation therapy setting: a project of meta-analysis and radiobiological modeling from individual patient data in randomized and observational data-sets - Raymond Miralbell
16:45	A Biomedical Research Facility at CERN based on the Low Energy Ion Ring - Adriano Garonna Slides
17:00	Nuclear Medicine - Ulli Koster Irene Virgolini (until 18:15)
17:00	Radiochemical aspects of radionuclide therapies - Helmut Maecke
17:30	²¹²Pb-labeled mAbs targeting CEA or HER2 during α-RIT of small peritoneal carcinomatosis – Dose effect relationship? - Jean-Pierre Pouget
17:45	152/161Tb-DOTA-RM6 biodistribution studies in prostate cancer bearing SCID mice and 149Tb sources from CERN-MEDICIS - Thierry Stora
18:00	A radionuclide generator of Erbium-165, an isotope for Auger Therapy - Gregory Severin

12:30	--- Lunch ---
13:30	Detectors & Imaging - Alberto Del Guerra Denis Dauvergne (until 14:15)
13:30	Different detector concepts for several imaging scenarios: from hadrontherapy monitoring to clinical imaging - Paola Solevi
13:45	An integrated monitoring system for the on-line assessment of particle therapy treatment accuracy - Vincenzo Patera Slides
14:00	Development of Advanced Quality Assurance Instrumentation for Hadrontherapy - David Watts Slides
14:15	New Technologies - Wolfgang Enghardt Anthony Lomax (until 15:45)
14:15	Novel detectors for range assessment in particle therapy - Peter Thirolf Slides
14:45	The ELIMED (Multidisciplinary and Medical applications at the ELI-Beams) network perspectives for laser driven beam applications - Andrea Attili
15:00	Harnessing laser-plasma accelerated ion beams for applications using Gabor lenses - Christopher Hughes
15:15	Positron emission tomography (PET) isotope production from laser-driven proton - John Wong Kai Ding
15:30	A novel TOF-PET detector based on organic scintillators - Pawel Moskal
15:45	--- Coffee Break ---
16:15	New Technologies - Wolfgang Enghardt Anthony Lomax (until 17:30)
16:15	Requirements from Oncology to Imaging Technologies - Heinz-Peter Schlemmer
16:45	Potential of Detection of fast Cherenkov Photons for Improved Time of Flight Positron Emission Tomography - Stefan Brunner
17:00	Experimental characterization of acoustic detection and imaging for Bragg peak localization in proton therapy - Katia Parodi
17:15	A new elastic image fusion model for lung deformation simulation in 4D dose calculations - Stefan Milz
18:30	Physics is beautiful and useful - Ugo Amaldi (TERA Foundation (IT)) (2) Slides Video in CDS
20:00	--- Cocktail ---

12:00	--- Lunch ---
13:00	New Insights into molecular mechanisms of radio-curability - Conchita Vens (until 14:15)
13:00	New insights into the complexities of NHEJ and HR repair - Simon Powell
13:25	Homologous recombination deficiency and radio-curability in mouse models for BRCA1/2-deficient breast cancer - Sven Rottenberg
13:50	Mechanism of HR dysfunction in single dose radiotherapy - Zvi Fuks
13:00	Optimizing treatment planning and delivery - Rahde Mohan (until 14:15)
13:00	New insights in IGRT for prostate cancer - Marcel Van Herk Slides
13:25	Adaptive radiotherapy - Vincent Gregoire
13:50	New health technologies and evidence-based medicine - Soren Bentzen
14:15	--- Coffee Break ---
14:45	Hadrons - Norman Coleman Manjit Dosanjh (until 16:25)
14:45	Carbon Ion Therapy: Actual and Future Strategies at HIT - Jurgen Debus
15:10	Present status of CNAO - Roberto Orecchia
15:35	Proton Radiation Therapy: Current Status of Clinical Trials - Thomas Delaney Slides
16:00	France HADRON: national infrastructure for hadrontherapy research including ETOILE, ARCHADE and protontherapy centers - Jacques Balosso Slides
14:45	Proffered papers - Physics I - Thomas Beyer David Townsend (until 16:25)
14:45	The development of a low energy facility for clinical trials of Boron Neutron Capture Therapy - Rob Edgecock
14:55	Interstitial Detectors for Synchronized Radiation Quality - Giulio Magrin Slides
15:05	An innovative on-line beam-monitoring detector based on the emission of secondary electrons - Saverio Braccini
15:15	Radiotherapy Dose Monitoring to Low-Dose Morphologic Imaging with Scanned Megavoltage X-rays - Paulo Crespo
15:25	Data models for the Compton camera acquisition and their influence on the reconstructed images - Voichita Maxim Slides
15:35	Detection of ionizing radiation by intrinsic optical fiber sensors: preliminary results - Laura Cella Slides
15:45	First investigations of Ultra-Thin 3D silicon detectors as microdosimeters - Celeste Fleta
15:55	Frequency difference electrical impedance tomography for imaging lung tumour - Chuan Li Yang
16:05	A novel dual-modality optical tomography and x-ray system for small animal radiation research platform - Ken Kang Hsin Wang
16:15	Digital Image Processing Techniques for Application in a Microbeam End-Station Microscopy - Antonios Georgantzoglou
16:30	Proffered papers - Biology I - Bleddyn Jones Kevin Prise (until 18:00)
16:30	DCE-MRI and DCE-US quantification in CWR22 prostate tumour xenografts - Natalia Arteaga-Marrero
16:40	Antitumor activity of combination therapy with TH-302 and irradiation in a rat rhabdomyosarcoma model - Sarah Peeters
16:50	Development of a novel ELISA for detecting inducible Hsp70 in serum - Stephanie Ertl
17:00	Advancing the small animal radiation research platform for pre-clinical radiation research - John Wong
17:10	Evaluation of Late Toxicity Risk for RT Patients through Geant 4 Simulation of X-Ray Dose Deposition - Frederic Brochu
17:20	Log file based dose calculations as a quality assurance tool in scanned beam proton radiotherapy - Gabriel Meier
17:30	A Novel Radioguided Surgery Technique Exploiting - decays - Riccardo Faccini
17:40	Investigation of irregular motion influence for future 4D In-beam PET imaging - Yuan Tian
17:50	Ongoing investigations on ion-based radiography and tomography - Lorena Magallanes
16:30	Proffered papers - Physics II (Hadrons) - Katia Parodi Guido Baroni (until 18:10)
16:30	Initial Qualification of the Irradiation Uncertainties in Ion Beam Therapy of Prostate Cancer - Antoni Rucinski
16:40	Can particle beam therapy be improved using helium ions? - A treatment planning study focusing on pediatric patients - Barbara Knaeusl
16:50	MCTP: a new Monte Carlo-based treatment planning tool for hadrontherapy - Giusseppe Battistoni Slides
17:00	PlanIt: Planning Ion therapy open platform for treatment plans testing and comparing - Faiza Bourhaleb
17:10	Robustness of range prediction in proton therapy using prompt gamma emission - Fiere Janssen
17:20	Simulation of Hadrontherapy In-beam monitoring at CNAO with the INSIDE detector - Piergiorgio Cerello Slides
17:30	Evaluation of existing ripple filter designs for clinical use at the MedAustron ion beam therapy facility - Loic Grevillot
17:40	The (non-) detectability of failures in motion mitigated ion beam delivery by means of in-beam PET - Kristin Stützer
17:50	Assessment and improvements of Geant4 models in the context of prompt-gamma hadrontherapy monitoring - George Dedes
18:00	Monte Carlo modelling of whole-body secondary cancer risk for conventional and emergent radiotherapy - Richard Hugtenburg
19:00	--- Gala Dinner ---

12:30	--- Lunch ---
13:30	ESO Session - E. van der Schueren Award - Alberto Costa (until 14:00)
13:30	The ART of translation - Marcel Verheij
14:00	Symposium in honour of Prof. Kian K. Ang- Translational research: the example of head and neck cancer - Ritsuko Komaki (until 15:15)
14:00	Eulogy of Professor Kian K. Ang - James Cox Slides
14:25	Milestones of Pr Kian Ang’s scientific contribution - Jacques Bernier
14:50	Molecular biology of head and neck carcinomas: old challenges, new insights - Kevin Harrington
15:15	--- Coffee Break ---
15:45	Proffered papers - Biology IV - Kevin McMullen Manjit Dosanjh (until 16:35)
15:45	Vimentin (EMT Marker Protein) Score As One of Predictors Resistance to Erlotinib and Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer on A Prospective Phase II Trial - Ritsuko Komaki Slides
15:55	Towards simpler and better prediction of relative biological effect (RBE) - Bleddyn Jones
16:05	Combined Radiochemotherapeutical Strategies for Microtubule Stabilizing Agent (MSA)-Resistant Tumors - Angela Broggini-Tenzer
16:15	Preclinical Assessment of Efficacy of Radiation Dose Redistribution Based on Intratumoral FDG-PET Uptake - Ludwig Dubois Slides
16:25	Fat percentage and hand grip strength in lung cancer: the influence on survival and toxicity - Kim Smits Slides
15:45	Proffered papers - Physics V (Detectors) - Ulli Köster Paul Lecoq (until 16:35)
15:45	Verification of dynamictrajectory radiotherapy based on Monte Carlo - Michael Fix
15:55	Development of a transparent photon detector for the online monitoring of IMRT beams - Rachel Delorme Slides
16:05	An Intensity Modulated Radiotherapy Beam Monitoring System using a Monolithic Active Pixel Sensor - Johannes Velthuis
16:15	Geant4 simulation of a dedicated beam line at the CNAO facility for the study of uveal melanomas - Edoardo Farina Slides
16:25	EndoTOFPET-US: A multimodal ultrasound and time of flight PET endoscope for developing new biomarkers for the prostate and pancreatic cancers - Etiennette Auffray
15:45	Proffered papers - Radiotherapy II - David Brizel (until 16:35)
15:45	The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects - Tiziana Rancati Slides
15:55	Potentiation of radiation response by a novel EGFR/DNA targeting molecule in a triple negative breast cancer model - Beatrice Fournier
16:05	Studying inter- and intrafraction motion mitigation with sequential 4D CTs of lung tumor patients - Romain Brevet Slides
16:15	Time resolved portal dosimetry for Volumetric Modulated Arc Therapy (VMAT) in lung cancer patients with atelectasis - Mark Podesta
16:25	Spot-scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of 39 Patients Treated at PSI - Carmen Ares
16:45	--- CERN visit ---
19:00	--- Cocktail in Globe ---

12:45	Symposium - Hadrons - Roberto Orecchia (until 14:00)
12:45	Evolution of technology to optimize the delivery of proton therapy: the third generation - Thomas Bortfeld
13:10	Robust optimization of IMPT dose distributions - Radhe Mohan Slides
13:35	Proton clinical correlates of patient throughput and cyclotron availability - Kevin McMullen Slides
12:45	Symposium - Imaging - Philippe Lambin (until 14:00)
12:45	Hypoxia Imaging - Marianne Nordsmark
13:10	Functional image-based target definition - Robert Jeraj Slides
13:35	Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas - David Brizel
12:45	Symposium - Tumor vascularization - Jens Overgaard (until 14:00)
12:45	Hypoxia modification in experimental tumours - Daniel Zips
13:10	The vascular supply and microenvironment of tumours and their significance for cancer therapy - Michael Horsman
13:35	Targeting hypoxia through autophagy - Kasper Rouschop
14:00	Symposium - Biomarker driven individualization of radiotherapy - from preclinical validation to clinical trials? - Michael Baumann (until 15:15)
14:00	Biomarker for stratification in radiotherapy - preclinical and early clinical models - Mechthild Krause
14:25	Imaging for prescription function - Daniela Thorwarth
14:50	How will we develop the evidence base for biologically individualized radiotherapy? - Tim Maughan
14:00	Symposium - Modulation of tumor and normal tissue response to radiation - Simon Powell (until 15:20)
14:00	Carbonic Anhydrase IX inhibitors: a new class of targeted agents - Philippe Lambin Slides
14:20	Immunosensitization by radiotherapy: the example of immunocytokines - Ludwig Dubois
14:40	Novel strategies to spare normal tissues from radiation damage - Marie-Catherine Vozenin
15:00	Intestinal Stem Cells are Radiation Resistant - Richard Kolesnick
15:20	Concluding remarks - Manjit Dosanjh (CERN) Jacques Bernier

Choose timezone